| scholarly article | Q13442814 |
| P50 | author | Jeanette H Leusen | Q57039110 |
| Thomas Valerius | Q53067216 | ||
| P2093 | author name string | Matthias Peipp | |
| Peter Boross | |||
| Louise Royle | |||
| Christian Kellner | |||
| Thomas Beyer | |||
| Li Phing Liew | |||
| Stefanie Derer | |||
| Michael Dechant | |||
| Stefan Lohse | |||
| Christina Brunke | |||
| P2860 | cites work | FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity | Q22254189 |
| Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function | Q26823047 | ||
| The Nonplanar Secretory IgA2 and Near Planar Secretory IgA1 Solution Structures Rationalize Their Different Mucosal Immune Responses | Q27653278 | ||
| Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets | Q28140238 | ||
| Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcalpha receptor (FcalphaR) CD89 | Q28141479 | ||
| IgA Fc receptors | Q28202739 | ||
| Human antibody-Fc receptor interactions illuminated by crystal structures | Q28252414 | ||
| Structural requirements for incorporation of J chain into human IgM and IgA. | Q55033512 | ||
| Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies | Q56896403 | ||
| Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage | Q56908749 | ||
| A Role for Protein Misfolding in Immunogenicity of Biopharmaceuticals | Q58895670 | ||
| Detection of IgA class circulating immune complexes bound to anti-C3d antibody in patients with IgA nephropathy | Q70340076 | ||
| Complexes of albumin and alpha 1-antitrypsin with Fc-fragment of IgA monomer are disulfide-bound to penultimate C-terminal cysteine in the C alpha 3-domain | Q70349357 | ||
| Intra- and inter-chain disulfide bridges of J chain in human S-IgA | Q70798059 | ||
| J chain is covalently bound to both monomer subunits in human secretory IgA | Q71574795 | ||
| The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA | Q74844601 | ||
| Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy | Q79272038 | ||
| Removal of cysteinylation from an unpaired sulfhydryl in the variable region of a recombinant monoclonal IgG1 antibody improves homogeneity, stability, and biological activity | Q81042585 | ||
| Monomeric and polymeric IgA show a similar association with the myeloid FcalphaRI/CD89 | Q83288035 | ||
| Carboxy-terminal structure of the α chain of human IgA [immunoglobulin A] myeloma proteins | Q93829869 | ||
| Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly | Q28283396 | ||
| Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells | Q28284490 | ||
| Location of a novel type of interpolypeptide chain linkage in the human protein HC-IgA complex (HC-IgA) and identification of a heterogeneous chromophore associated with the complex | Q28285521 | ||
| Multiple roles for the major histocompatibility complex class I- related receptor FcRn | Q33932754 | ||
| Production of recombinant protein therapeutics in cultivated mammalian cells | Q33982884 | ||
| The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions | Q34453640 | ||
| Antibody-based therapeutics to watch in 2011 | Q34570079 | ||
| The immune geography of IgA induction and function | Q34903056 | ||
| Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins | Q35053379 | ||
| Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophages. | Q36127055 | ||
| The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes | Q36368639 | ||
| IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy | Q36456627 | ||
| IgA receptors in health and disease | Q36546463 | ||
| Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding | Q36967139 | ||
| Effector mechanisms of therapeutic antibodies against ErbB receptors | Q37201804 | ||
| The role of thiols and disulfides on protein stability. | Q37524089 | ||
| Structure and function relationships in IgA. | Q37936765 | ||
| IgA EGFR antibodies mediate tumour killing in vivo | Q39114924 | ||
| Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killing. | Q39593092 | ||
| Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines | Q39709073 | ||
| Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cells | Q39724220 | ||
| Serum-free production and purification of chimeric IgA antibodies | Q39854415 | ||
| M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. | Q39870660 | ||
| Divergent immunoglobulin g subclass activity through selective Fc receptor binding | Q40344836 | ||
| Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing | Q40694990 | ||
| The effect of peptide deletions on the glycosylation of murine immunoglobulin M heavy chains | Q41731756 | ||
| Biosynthesis of immunoglobulin A (IgA) and immunoglobulin M (IgM). Requirement for J chain and a disulphide-exchanging enzyme for polymerization. | Q42559348 | ||
| Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. | Q42940097 | ||
| Characterization of antibody aggregation: role of buried, unpaired cysteines in particle formation | Q43289805 | ||
| Cysteine residues required for the attachment of the light chain in human IgA2. | Q44187664 | ||
| Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems | Q44362265 | ||
| Endoplasmic reticulum resident, immunoglobulin joining chain, can be secreted by perturbation of the calcium concentration in the endoplasmic reticulum | Q45007134 | ||
| Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan. | Q46151045 | ||
| The influences of hinge length and composition on the susceptibility of human IgA to cleavage by diverse bacterial IgA1 proteases | Q46535441 | ||
| HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. | Q46808539 | ||
| Free sulfhydryl measurement as an indicator of antibody stability | Q47418805 | ||
| Solution structure determination of monomeric human IgA2 by X-ray and neutron scattering, analytical ultracentrifugation and constrained modelling: a comparison with monomeric human IgA1. | Q47692349 | ||
| Comparison of IgA-alpha1-antitrypsin levels in rheumatoid arthritis and seronegative oligoarthritis: complex formation is not associated with inflammation per se. | Q47995046 | ||
| Structural requirements for the interaction of human IgA with the human polymeric Ig receptor. | Q51812591 | ||
| Effector mechanisms of recombinant IgA antibodies against epidermal growth factor receptor. | Q53533176 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 936-945 | |
| P577 | publication date | 2013-11-01 | |
| P1433 | published in | Monoclonal Antibodies | Q6714645 |
| P1476 | title | Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2m(1) antibody | |
| P478 | volume | 5 |
| Q37138274 | A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA. |
| Q26799080 | Anti-infective immunoadhesins from plants |
| Q38717198 | Engineering broadly neutralizing antibodies for HIV prevention and therapy |
| Q36216363 | Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding |
| Q41704272 | Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy |
| Q92248471 | Production, characterization, and in vivo half-life extension of polymeric IgA molecules in mice |
| Q35569901 | Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life |
| Q34217953 | Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells |
| Q38254478 | Upstream and downstream processing of recombinant IgA. |
Search more.